Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019363
Filing Date
2019-05-15
Accepted
2019-05-15 15:14:04
Documents
43
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gnpx-10q_20190331.htm 10-Q 969409
2 EX-31.1 gnpx-ex311_6.htm EX-31.1 16347
3 EX-31.2 gnpx-ex312_8.htm EX-31.2 17719
4 EX-32.1 gnpx-ex321_7.htm EX-32.1 8431
  Complete submission text file 0001564590-19-019363.txt   3168503

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnpx-20190331.xml EX-101.INS 374370
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20190331.xsd EX-101.SCH 37527
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20190331_cal.xml EX-101.CAL 23498
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20190331_def.xml EX-101.DEF 110939
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20190331_lab.xml EX-101.LAB 288760
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20190331_pre.xml EX-101.PRE 199338
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 19827494
SIC: 2834 Pharmaceutical Preparations